CABA
CABA
NASDAQ · Biotechnology

Cabaletta Bio Inc

$1.03
-0.03 (-2.37%)
As of Nov 19, 8:40 PM ET ·
Day Range $1.00 — $1.08
52W Range $1.18 — $4.23
Open$1.06
Previous Close$1.06
Day High$1.08
Day Low$1.00
52W High$4.23
52W Low$1.18
Volume—
Avg Volume4.57M
Market Cap281.52M
P/E Ratio—
EPS$-1.57
SectorBiotechnology

Analyst Ratings

Strong Buy
16 analysts
13 Buy 3 Hold 0 Sell
Price Target +3,763.1% upside
Current
$1.03
Target
$39.79
$29.42 $39.79 avg $58.63

Key Financials

FY 2025 FY 2024 FY 2023
Revenue 65.93M 59.67M 56.91M
Net Income 10.90M 11.06M 10.11M
Profit Margin 16.5% 18.5% 17.8%
EBITDA 19.62M 16.47M 16.10M
Free Cash Flow 6.94M 6.70M 7.67M
Rev Growth +19.8% +7.9% +20.9%
Debt/Equity 0.22 0.21 0.21

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $283.54 -0.86% 50.3 520.47B
AMGN Amgen Inc $438.82 -1.14% 26.9 252.64B
GILD Gilead Sciences Inc $166.53 -1.45% — 208.95B
VRTX Vertex Pharmaceuticals Inc $520.66 -2.94% 33.9 134.82B
REGN Regeneron Pharmaceuticals $923.34 -2.35% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $147.82 -1.06% 7.7 20.98B

Quick Stats

Market Cap281.52M
P/E Ratio—
EPS$-1.57
Volume—
SectorBiotechnology